Activity of uveitis during etanercept and infliximab treatment at the end of the follow-up compared with the baseline in 45 patients with juvenile idiopathic arthritis
| Response of uveitis | Etanercept | Infliximab | Total |
|---|---|---|---|
| Treatment failure, n (%) | 13 (54.2) | 4 (19) | 17 (37.8) |
| No change, n (%) | 6 (25) | 8 (38.1) | 14 (31.1) |
| Improved activity, n (%) | 5 (20.8) | 9 (42.9) | 14 (31.1) |